Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Mendes, Alinea; * | Herrmann, François R.a | Scheffler, Maxb | Gabriel, Gemmaa | Sveikata, Lukasc | Rakotomiaramanana, Barinjakaa | Frisoni, Giovanni B.a | Zekry, Dinaa; d | Gold, Gabriela
Affiliations: [a] Memory Center, Division of Geriatrics, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland | [b] Department of Radiology, Geneva University Hospitals, Geneva, Switzerland | [c] Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland | [d] Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland
Correspondence: [*] Correspondence to: Aline Mendes, Trois-Chêne Hospital, Chemin du Pont-Bochet 3, 1226, Thônex, Switzerland. Tel.: +410795538365; E-mail: [email protected].
Abstract: Background:Cortical superficial siderosis (cSS) is a hemorrhagic marker of blood-brain barrier disruption detected in brain MRI. Together with cerebral microbleeds (CMB), they are recognized as a small vessel disease marker associated with cerebral amyloid angiopathy. Objective:This study aims to determine the prevalence and the characteristics of cSS in a memory clinic population. Methods:Cross-sectional retrospective analysis of 613 patients from Geneva University Hospitals memory clinic. All patients underwent standardized brain MRI and neuropsychological assessment with diagnosis confirmed by an expert. The presence of cSS was visually assessed and classified as focal (restricted to 3 sulci) or disseminated within the correspondent topography. CMB were classified according to the Microbleed Anatomical Rating Scale. Results:cSS was detected in 26/613 patients (4.2%), classified as disseminated in 5/26 cases (19%). Alzheimer’s disease (AD) and AD associated with a significant vascular component were the diagnoses more frequently related to cSS (18/26; 69%). Patients with cSS had an increased prevalence of both hypertension (81% versus 57%; p = 0.015) and WMH burden (p = 0.012). The overall prevalence of cerebral microbleeds (69% versus 32%; p < 0.01), as well as their mean number (0.69±0.47 versus 0.32±0.46; p < 0.01) were both increased in patients with cSS. In the logistic regression model, the presence of 5 or more CMB (OR 11.35; 95% CI 4.68–27.55; p < 0.01) and hypertension (OR 3.31; 95% CI 1.19–9.15; p = 0.021) were significantly associated with cSS. Conclusions:cSS is observed in patients diagnosed with AD and AD with a vascular component, being independently associated with multiple CMB and hypertension.
Keywords: Alzheimer’s disease, cerebral amyloid angiopathy, cerebral microbleeds, cerebral small vessel disease, cortical superficial siderosis, vascular dementia, white matter hyperintensities
DOI: 10.3233/JAD-190619
Journal: Journal of Alzheimer's Disease, vol. 73, no. 4, pp. 1467-1479, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]